Yijin Gao, MD. Ph.D.
Education
Graduated from Shanghai Medical University with a Bachelor's degree in Medicine in 1995.
Graduated from Shanghai Medical University in 1999 with a Master of Medicine degree.
Graduated from Shanghai Medical University in 2002 with a Doctor of Philosophy degree.
Work Experience
2002-2013, Department of Hematology, children’s hospital of Fudan University, Resident, Attending Physician, Associate Chief physician.
2013 to present, Chief physician. Department of Hematology and Oncology, Shanghai Children’s Medical Center, School of Medicine, Chief physicianS hanghai Jiao Tong University.
Research interest
1) Gao YJ, Fang YJ, Gao J, et al. A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children's Cancer Group. Ann Hematol. 2022 Sep;101(9):2035.
2) Yuan Q, He Q, Mi Q, et al. Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children's institution Ann Hematol. 2021 Apr;100(4):1093-1095.
Membership of professional societies
1) Deputy Leader of the 18th Oncology Group of the Pediatric Branch of Chinese Medical Association.
2) Chairman of the Children's Oncology Professional Committee of Shanghai Anti Cancer Association.
Yijin Gao, MD. Ph.D.
Education
Graduated from Shanghai Medical University with a Bachelor's degree in Medicine in 1995.
Graduated from Shanghai Medical University in 1999 with a Master of Medicine degree.
Graduated from Shanghai Medical University in 2002 with a Doctor of Philosophy degree.
Work Experience
2002-2013, Department of Hematology, children’s hospital of Fudan University, Resident, Attending Physician, Associate Chief physician.
2013 to present, Chief physician. Department of Hematology and Oncology, Shanghai Children’s Medical Center, School of Medicine, Chief physicianS hanghai Jiao Tong University.
Research interest
1) Gao YJ, Fang YJ, Gao J, et al. A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children's Cancer Group. Ann Hematol. 2022 Sep;101(9):2035.
2) Yuan Q, He Q, Mi Q, et al. Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children's institution Ann Hematol. 2021 Apr;100(4):1093-1095.
Membership of professional societies
1) Deputy Leader of the 18th Oncology Group of the Pediatric Branch of Chinese Medical Association.
2) Chairman of the Children's Oncology Professional Committee of Shanghai Anti Cancer Association.